As human beings, we tend to fear the unknown or unfamiliar. Getting a diagnosis can be terrifying, and the need for invasive treatment procedures such as chemotherapy can take an extra toll on one’s mental health. Have you developed heightened levels of anxiety due to a constant worry of hereditary cancer predisposition? Is this because you or someone in your family has become affected by a hereditary condition called Lynch Syndrome?
According to the Centers for Disease Control and Prevention, Lynch syndrome causes about 4,000 colorectal cancers and 1,800 uterine (endometrial) cancers per year. Lynch syndrome targets families, predisposing relatives to cancer at a younger than average age. Those who possess the gene mutation carry up to an 85% risk of contracting colon cancer and have a higher than average prospect for endometrial, stomach, pancreas, urinary tract, prostate, ovarian, breast, skin cancers, and more.
The gene mutations responsible for this hereditary condition include but are not limited to specific mismatch repair of MLH1, MSH2, MSH6, PMS2, and EPCAM-TACSTD1. Although variations in these genes may predispose you to cancer, not everyone who carries these mutations develop malignant tumors. Privy Health Cancer Insight provides actionable results to help you take control of your health and achieve peace of mind, or prepare for the long road ahead.
Lynch is the most prevalent inherited cancer syndrome affecting both men and women and is not as rare as scientists previously thought. In fact, in the U.S. alone, over one million individuals are projected to have the mutated gene causing the predisposition to cancers – however, 95% are unaware they have it. If one of your parents tests positive for Lynch syndrome, you have a 50% chance of being a carrier as well. If you test positive, your children have a 50/50 chance to inherit the gene. Only if you test negative for the gene will it not be passed on to your future children. Lynch syndrome does not skip generations.
Privy Health Cancer Insight allows you to preserve and empower your health. If a Lynch mutation is present, results can assist your doctor in generating appropriate treatment decisions and determine the best plan of action. Lynch syndrome is not a rare condition, but it is severely underdiagnosed.
CGX screening tests are used for early detection when treatment is most effective and strengthens cancer prevention, all while dramatically increasing your rate of survival. It can also provide insight into how particular predispositions may play a role within your family. That not only includes your children but siblings, aunts, uncles, nieces, and cousins.